Vanda Pharmaceuticals, Inc. (VNDA)
6.21
+0.03
(+0.49%)
USD |
NASDAQ |
May 21, 16:00
6.195
-0.02
(-0.24%)
After-Hours: 19:59
Vanda Pharmaceuticals Research and Development Expense (TTM) : 101.99M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| AnaptysBio, Inc. | 128.24M |
| Amgen, Inc. | 7.514B |
| Gossamer Bio, Inc. | 179.10M |
| BridgeBio Pharma, Inc. | 467.16M |
| Geron Corp. | 73.59M |